|
ZNF529 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.21870002978142E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.41730000460905E-08 |
| Normal-vs-Stage2 |
2.37349999999692E-05 |
| Normal-vs-Stage3 |
4.94239982273825E-10 |
| Normal-vs-Stage4 |
1.07169999996604E-06 |
| Stage1-vs-Stage2 |
9.265600E-01 |
| Stage1-vs-Stage3 |
1.960400E-02 |
| Stage1-vs-Stage4 |
1.352170E-01 |
| Stage2-vs-Stage3 |
1.536780E-01 |
| Stage2-vs-Stage4 |
2.433800E-01 |
| Stage3-vs-Stage4 |
9.363400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.47829987035198E-10 |
| Normal-vs-AfricanAmerican |
2.356200E-04 |
| Normal-vs-Asian |
2.398100E-02 |
| Caucasian-vs-AfricanAmerican |
7.988600E-01 |
| Caucasian-vs-Asian |
8.366300E-04 |
| AfricanAmerican-vs-Asian |
5.345500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09279999996426E-06 |
| Normal-vs-Female |
7.76859687690035E-11 |
| Male-vs-Female |
1.153230E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.01990000176156E-08 |
| Normal-vs-Age(41-60Yrs) |
8.15129996833974E-09 |
| Normal-vs-Age(61-80Yrs) |
1.89540000361532E-08 |
| Normal-vs-Age(81-100Yrs) |
5.443600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.873600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.362000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.314200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.896600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.548600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.829000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.431500E-04 |
| Classical-VS-Follicular |
8.341000E-01 |
| Classical-VS-Other |
3.101800E-01 |
| Classical-VS-Normal |
9.30089999462425E-08 |
| Tall-VS-Follicular |
4.840200E-04 |
| Tall-VS-Other |
4.256600E-03 |
| Tall-VS-Normal |
4.90839591194003E-11 |
| Follicular-VS-Other |
3.544800E-01 |
| Follicular-VS-Normal |
1.55728999999827E-05 |
| Other-VS-Normal |
2.601400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.73519999982597E-08 |
| Normal-vs-N1 |
5.171000E-04 |
| N0-vs-N1 |
7.390400E-01 |
|
|
